EVMNEvommune Inc. Common Stock
14.02USD-6.60%Mkt Cap: 508.82M $P/E: —3d ago
Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap508.82M $
Enterprise Value300.32M $
Revenue (TTM)10.00M $
Gross Profit10.00M $
Net Income (TTM)-68.87M $
Revenue/Share0.4380 USD
Last Price14.02 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees48
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.03
PEG—
EV/EBITDA-2.99
EV/Revenue30.03
P/S49.25
P/B1.77
EPS (TTM)-10.69
EPS (Forward)-3.36
52W Range
10.4716% of range33.20
52W High33.20 USD
52W Low10.47 USD
Profitability
Gross Margin100.00%
Oper. Margin-1018.94%
EBITDA Margin0.00%
Profit Margin-529.77%
ROE-33.50%
ROA-30.62%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-76.44M $
CapEx (TTM)235.00K $
FCF Margin-391.28%
FCF Yield-7.69%
Net Debt-192.16M $
Net Debt/EBITDA1.91
Balance Sheet
Debt/Equity0.01
Current Ratio11.68
Quick Ratio11.48
Book Value/Sh7.651 USD
Cash/Share5.533 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.57 USD
Upside (mean)+96.7%
Target Range22.00 USD – 32.00 USD
$22.00+96.7% to mean$32.00
# Analysts7
Ownership
Shares Out.36.29M
Float19.88M
Insiders3.15%
Institutions114.56%
Short Interest
Short Ratio5.4d
Short % Float18.28%
Short % Out.12.35%
Shares Short4.48M
Short (prev mo.)4.78M
Technical
SMA 5015.03 (-6.7%)
SMA 20020.27 (-30.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)515.98K
Avg Vol (10d)411.27K
Technical Indicators
RSI (14)51.2
MACD0.0618
MACD Signal-0.3348
MACD Hist.+0.3966
BB Upper15.76 USD
BB Middle12.93 USD
BB Lower10.10 USD
BB Width43.80%
ATR (14)0.9218 USD
Vol Ratio (20d)0.60x